Archives

  • 2026-04
  • 2026-03
  • 2026-02
  • 2026-01
  • 2025-12
  • 2025-11
  • 2025-10
  • 2025-09
  • 2025-03
  • 2025-02
  • 2025-01
  • 2024-12
  • 2024-11
  • 2024-10
  • 2024-09
  • 2024-08
  • 2024-07
  • 2024-06
  • 2024-05
  • 2024-04
  • 2024-03
  • 2024-02
  • 2024-01
  • 2023-12
  • 2023-11
  • 2023-10
  • 2023-09
  • 2023-08
  • 2023-06
  • 2023-05
  • 2023-04
  • 2023-03
  • 2023-02
  • 2023-01
  • 2022-12
  • 2022-11
  • 2022-10
  • 2022-09
  • 2022-08
  • 2022-07
  • 2022-06
  • 2022-05
  • 2022-04
  • 2022-03
  • 2022-02
  • 2022-01
  • 2021-12
  • 2021-11
  • 2021-10
  • 2021-09
  • 2021-08
  • 2021-07
  • 2021-06
  • 2021-05
  • 2021-04
  • 2021-03
  • 2021-02
  • 2021-01
  • 2020-12
  • 2020-11
  • 2020-10
  • 2020-09
  • 2020-08
  • 2020-07
  • 2020-06
  • 2020-05
  • 2020-04
  • 2020-03
  • 2020-02
  • 2020-01
  • 2019-12
  • 2019-11
  • 2019-10
  • 2019-09
  • 2019-08
  • 2019-07
  • 2019-06
  • 2018-07
  • Cy5 TSA Fluorescence System Kit: High-Sensitivity Signal ...

    2025-11-03

    Cy5 TSA Fluorescence System Kit: High-Sensitivity Signal Amplification for Low-Abundance Target Detection

    Executive Summary: The Cy5 TSA Fluorescence System Kit (SKU: K1052) delivers up to 100-fold signal amplification in immunohistochemistry (IHC), in situ hybridization (ISH), and immunocytochemistry (ICC) using HRP-catalyzed tyramide deposition and Cyanine 5 labeling (APExBIO). Fluorescence labeling is completed in under 10 minutes, with stable excitation/emission at 648/667 nm. The kit maintains high detection specificity while reducing primary antibody or probe usage. Its performance is verified for low-abundance protein and nucleic acid targets in fixed tissues and cells (Chen et al., 2025). Storage stability is up to 2 years for all components under recommended conditions.

    Biological Rationale

    Detection of low-abundance biomolecules in tissues and cells is critical for research in inflammation, cardiovascular diseases, and cancer biology (Chen et al., 2025). Many targets of interest, such as NLRP3 inflammasome components, are present at low copy numbers, making conventional immunofluorescence or ISH insufficiently sensitive (Related article). Tyramide signal amplification (TSA) leverages enzymatic catalysis to deposit dense arrays of fluorescent labels at sites of HRP activity, enhancing detection without increasing background noise. Enhanced detection sensitivity is especially vital for studies where target protein or mRNA levels are downregulated, such as in disease models or following gene knockdown experiments. The Cy5 TSA Fluorescence System Kit addresses these needs by providing a robust, rapid, and reproducible amplification platform that integrates seamlessly into standard microscopy workflows.

    Mechanism of Action of Cy5 TSA Fluorescence System Kit

    The Cy5 TSA Fluorescence System Kit employs horseradish peroxidase (HRP)-conjugated secondary antibodies to catalyze the local deposition of Cyanine 5-labeled tyramide molecules. Upon addition of hydrogen peroxide, HRP oxidizes the tyramide substrate, producing highly reactive tyramide radicals. These radicals covalently bind to electron-rich tyrosine residues proximal to the HRP enzyme (see mechanistic primer). The result is a dense, stable fluorescent signal confined to the site of HRP localization. The Cyanine 5 fluorophore emits at 667 nm when excited at 648 nm, a spectral window with low tissue autofluorescence, enabling clear imaging in complex samples. The total amplification process is completed in under 10 minutes, with minimal reagent consumption and high reproducibility.

    Evidence & Benchmarks

    • The Cy5 TSA Fluorescence System Kit achieves approximately 100-fold signal amplification over conventional fluorescence detection methods in IHC and ISH (APExBIO).
    • Fluorescent labeling via Cyanine 5-tyramide is highly specific, with low background even in complex tissue matrices (Cy5 TSA: Advanced Signal Amplification).
    • Signal amplification is rapid, with the complete deposition process finishing in less than 10 minutes at room temperature (per manufacturer protocol, product page).
    • HRP-catalyzed tyramide deposition enables detection of NLRP3 inflammasome components in low-abundance disease models, supporting findings in atherosclerosis and inflammation (Chen et al., 2025).
    • Storage stability for Cyanine 5 Tyramide is validated at -20°C for up to 2 years; Amplification Diluent and Blocking Reagent remain stable at 4°C for 2 years (APExBIO).

    This article extends the strategic and mechanistic depth found in "Amplifying Discovery: Mechanistic and Strategic Insights" by providing updated evidence benchmarks and pragmatic workflow guidance for the Cy5 TSA Fluorescence System Kit.

    Applications, Limits & Misconceptions

    Major Applications:

    • Immunohistochemistry (IHC) for low-abundance protein targets in fixed tissues.
    • In situ hybridization (ISH) for RNA detection, including rare transcripts.
    • Immunocytochemistry (ICC) for cultured cell analyses.
    • Multiplexed fluorescence microscopy for spatial mapping of multiple targets.
    • Detection of signaling proteins, transcription factors, and post-translational modifications at single-cell or subcellular resolution (see advanced translational guidance).

    Common Pitfalls or Misconceptions

    • TSA amplification does not rescue signal if the primary antibody lacks specificity; off-target binding will also be amplified.
    • The kit is not designed for live-cell imaging, as tyramide deposition requires fixed, permeabilized samples.
    • Endogenous peroxidase activity (e.g., in blood-rich tissues) must be quenched to avoid background amplification.
    • Overamplification can result in artifactual signal spread if reaction times or concentrations are not optimized.
    • Cyanine 5 fluorescence is not suitable for detection in channels below 650 nm; spectral overlap must be considered in multiplex designs (details in inflammation research applications).

    Workflow Integration & Parameters

    The Cy5 TSA Fluorescence System Kit is compatible with conventional and confocal fluorescence microscopes equipped with 640–650 nm excitation lasers and 660–680 nm emission filters. Recommended workflow steps are:

    1. Fix and permeabilize tissue or cells using standard protocols.
    2. Block with provided Blocking Reagent (room temperature, 30 min).
    3. Incubate with primary antibody or probe (user-optimized concentration).
    4. Add HRP-conjugated secondary antibody (1:500–1:1000 dilution, 30–60 min).
    5. Apply Cyanine 5 tyramide working solution in Amplification Diluent (prepare fresh, protect from light).
    6. Incubate for 5–10 min at room temperature, then wash thoroughly.
    7. Mount and image; typical signal is stable under standard mounting media and can be imaged immediately.

    Reduced primary antibody consumption is achieved due to the amplification step. For best results, optimize antibody concentrations and incubation times for each application. Cyanine 5 tyramide should be stored at -20°C, protected from light; Amplification Diluent and Blocking Reagent are stored at 4°C.

    Conclusion & Outlook

    The Cy5 TSA Fluorescence System Kit (K1052) enables highly sensitive, rapid, and robust signal amplification for fluorescence-based detection platforms in biomedical research. It is particularly advantageous for studies of low-abundance targets, such as those relevant to inflammation and cardiovascular disease models. By integrating HRP-catalyzed tyramide deposition with stable Cyanine 5 labeling, the kit supports advanced multiplexing, spatial biology, and translational research. As research into rare signaling events and single-cell resolution advances, the Cy5 TSA Fluorescence System Kit provides a scalable platform for next-generation molecular detection (see spatial analysis perspectives).